Literature DB >> 8862932

Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin-C.

P J Dougherty1, D R Hardten, R L Lindstrom.   

Abstract

A 59-year-old man underwent pterygium excision with intraoperative application of 0.2 mg/ml (0.02%) mitomycin-C placed on the scleral bed for 3 min. A sliding conjunctival flap was used to cover the exposed limbus and sclera. Five weeks after the original surgery, the patient had mild trauma and noted decreased vision. At that time, it was noted that he had a corneoscleral melt with perforation. The patient was managed with a lamellar transplant in this area. Intraoperative single-dose application of topical mitomycin-C can be associated with serious complications. This case occurred despite the fact that this patient received the lowest dose used in a series of 25 eyes using the same technique without any other complications. Although topical mitomycin-C is effective as an adjunct to pterygium surgery and may reduce recurrence, the safety and efficacy of various concentrations and dosing schedules need further definition.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8862932

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  36 in total

1.  Photodynamic therapy for wound-healing modulation in pterygium surgery. A clinical pilot study.

Authors:  Arno Hueber; Salvatore Grisanti; Michael Diestelhorst
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-04-15       Impact factor: 3.117

2.  Pterygium surgery with mitomycin and tarsorrhaphy.

Authors:  Thomas O Wood; Ellen E Williams; Danielle L Hamilton; Bryan L Williams
Journal:  Trans Am Ophthalmol Soc       Date:  2005

3.  Identification and Correction of Restrictive Strabismus After Pterygium Excision Surgery.

Authors:  Sally L Baxter; Brian J Nguyen; Michael Kinori; Don O Kikkawa; Shira L Robbins; David B Granet
Journal:  Am J Ophthalmol       Date:  2019-02-14       Impact factor: 5.258

Review 4.  Developments and current approaches in the treatment of pterygium.

Authors:  Dilek Hacıoğlu; Hidayet Erdöl
Journal:  Int Ophthalmol       Date:  2016-09-23       Impact factor: 2.031

5.  Mitomycin C, amniotic membrane transplantation and limbal conjunctival autograft for treating multirecurrent pterygia with symblepharon and motility restriction.

Authors:  Yu-Feng Yao; Wen-Ya Qiu; Yong-Ming Zhang; Scheffer C G Tseng
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-12       Impact factor: 3.117

6.  Randomised controlled study of conjunctival autograft versus amniotic membrane graft in pterygium excision.

Authors:  P Luanratanakorn; T Ratanapakorn; O Suwan-Apichon; R S Chuck
Journal:  Br J Ophthalmol       Date:  2006-07-12       Impact factor: 4.638

7.  Efficacy and Safety of a Large Conjunctival Autograft for Recurrent Pterygium.

Authors:  Jun Seok Lee; Sang Won Ha; Sung Yu; Gwang Ja Lee; Young Jeung Park
Journal:  Korean J Ophthalmol       Date:  2017-12

8.  A randomised trial comparing 0.02% mitomycin C and limbal conjunctival autograft after excision of primary pterygium.

Authors:  A L Young; G Y S Leung; A K K Wong; L L Cheng; D S C Lam
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

Review 9.  The clinical applications of fluorouracil in ophthalmic practice.

Authors:  Lekha M Abraham; Dinesh Selva; Robert Casson; Igal Leibovitch
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  One-year outcomes of a bilateral randomised prospective clinical trial comparing PRK with mitomycin C and LASIK.

Authors:  A D Wallau; M Campos
Journal:  Br J Ophthalmol       Date:  2009-11-04       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.